Elizabeth J Angelakis, MD | |
703 Riverway Pl, Bedford, NH 03110-6768 | |
(603) 627-1661 | |
(603) 669-6944 |
Full Name | Elizabeth J Angelakis |
---|---|
Gender | Female |
Speciality | Diagnostic Radiology |
Experience | 31 Years |
Location | 703 Riverway Pl, Bedford, New Hampshire |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255437984 | NPI | - | NPPES |
3192253 | Medicaid | MA | |
P01222166 | Other | NH | RAILROAD MEDICARE |
3070806 | Medicaid | NH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 158634 (Massachusetts) | Secondary |
2085R0202X | Radiology - Diagnostic Radiology | 16206 (New Hampshire) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Catholic Medical Center | Manchester, NH | Hospital |
Elliot Hospital | Manchester, NH | Hospital |
Speare Memorial Hospital | Plymouth, NH | Hospital |
Southern Nh Medical Center | Nashua, NH | Hospital |
Monadnock Community Hospital | Peterborough, NH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Southern New Hampshire Radiology Consultants Pc | 2769436088 | 25 |
News Archive
Researchers at the California Institute of Technology have developed an autonomous molecular machine comprising a single strand of DNA that can move around, collect specific molecules and sort them into predefined locations. Furthermore, this nanobot has been designed in such a way that requires no external source of energy or instruction.
Scientists have analysed data from around the world to examine the accuracy of antibody tests for COVID-19, and have shown that the timing of testing is critical. The tests do not work accurately when administered at the wrong time.
Investigators in the Blood and Marrow Transplant Program at Rutgers Cancer Institute of New Jersey compared outcomes for patients having undergone allogeneic stem cell transplant when post-transplant cyclophosphamide (PCy, a type of chemotherapy) was added as part of standard treatment to prevent disease through an immune response (immunoprophylaxis) than if this standard treatment was given alone.
The AP reports that "previously you had to sign up by the middle of February, guaranteeing that your coverage would take effect March 1, in order to avoid fines for being uninsured."
IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, today announced that it has completed the previously announced divestiture of its non-core electronics business, Anaheim, Calif.-based RTI Electronics, Inc. IntriCon has sold the business to an affiliate of Shackleton Equity Partners, a Los Angeles-based private equity group.
› Verified 2 days ago
Entity Name | Littleton Hospital Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144223702 PECOS PAC ID: 6901796556 Enrollment ID: O20040322000785 |
News Archive
Researchers at the California Institute of Technology have developed an autonomous molecular machine comprising a single strand of DNA that can move around, collect specific molecules and sort them into predefined locations. Furthermore, this nanobot has been designed in such a way that requires no external source of energy or instruction.
Scientists have analysed data from around the world to examine the accuracy of antibody tests for COVID-19, and have shown that the timing of testing is critical. The tests do not work accurately when administered at the wrong time.
Investigators in the Blood and Marrow Transplant Program at Rutgers Cancer Institute of New Jersey compared outcomes for patients having undergone allogeneic stem cell transplant when post-transplant cyclophosphamide (PCy, a type of chemotherapy) was added as part of standard treatment to prevent disease through an immune response (immunoprophylaxis) than if this standard treatment was given alone.
The AP reports that "previously you had to sign up by the middle of February, guaranteeing that your coverage would take effect March 1, in order to avoid fines for being uninsured."
IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, today announced that it has completed the previously announced divestiture of its non-core electronics business, Anaheim, Calif.-based RTI Electronics, Inc. IntriCon has sold the business to an affiliate of Shackleton Equity Partners, a Los Angeles-based private equity group.
› Verified 2 days ago
Entity Name | Southern New Hampshire Radiology Consultants Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780648915 PECOS PAC ID: 2769436088 Enrollment ID: O20050309000947 |
News Archive
Researchers at the California Institute of Technology have developed an autonomous molecular machine comprising a single strand of DNA that can move around, collect specific molecules and sort them into predefined locations. Furthermore, this nanobot has been designed in such a way that requires no external source of energy or instruction.
Scientists have analysed data from around the world to examine the accuracy of antibody tests for COVID-19, and have shown that the timing of testing is critical. The tests do not work accurately when administered at the wrong time.
Investigators in the Blood and Marrow Transplant Program at Rutgers Cancer Institute of New Jersey compared outcomes for patients having undergone allogeneic stem cell transplant when post-transplant cyclophosphamide (PCy, a type of chemotherapy) was added as part of standard treatment to prevent disease through an immune response (immunoprophylaxis) than if this standard treatment was given alone.
The AP reports that "previously you had to sign up by the middle of February, guaranteeing that your coverage would take effect March 1, in order to avoid fines for being uninsured."
IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, today announced that it has completed the previously announced divestiture of its non-core electronics business, Anaheim, Calif.-based RTI Electronics, Inc. IntriCon has sold the business to an affiliate of Shackleton Equity Partners, a Los Angeles-based private equity group.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Elizabeth J Angelakis, MD 703 Riverway Pl, Bedford, NH 03110-6768 Ph: (603) 627-1661 | Elizabeth J Angelakis, MD 703 Riverway Pl, Bedford, NH 03110-6768 Ph: (603) 627-1661 |
News Archive
Researchers at the California Institute of Technology have developed an autonomous molecular machine comprising a single strand of DNA that can move around, collect specific molecules and sort them into predefined locations. Furthermore, this nanobot has been designed in such a way that requires no external source of energy or instruction.
Scientists have analysed data from around the world to examine the accuracy of antibody tests for COVID-19, and have shown that the timing of testing is critical. The tests do not work accurately when administered at the wrong time.
Investigators in the Blood and Marrow Transplant Program at Rutgers Cancer Institute of New Jersey compared outcomes for patients having undergone allogeneic stem cell transplant when post-transplant cyclophosphamide (PCy, a type of chemotherapy) was added as part of standard treatment to prevent disease through an immune response (immunoprophylaxis) than if this standard treatment was given alone.
The AP reports that "previously you had to sign up by the middle of February, guaranteeing that your coverage would take effect March 1, in order to avoid fines for being uninsured."
IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, today announced that it has completed the previously announced divestiture of its non-core electronics business, Anaheim, Calif.-based RTI Electronics, Inc. IntriCon has sold the business to an affiliate of Shackleton Equity Partners, a Los Angeles-based private equity group.
› Verified 2 days ago
Dr. Joseph K. Azar, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 703 Riverway Pl, Bedford, NH 03110 Phone: 603-627-1661 Fax: 603-669-6944 | |
Dr. Wane G Joselow, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 703 Riverway Pl, Bedford, NH 03110 Phone: 603-668-7096 Fax: 603-669-6944 | |
Dr. Christopher G Eckel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 703 Riverway Pl, Bedford, NH 03110 Phone: 603-668-7096 Fax: 603-669-6944 | |
Dr. Channing S Swan, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 703 Riverway Pl, Bedford, NH 03110 Phone: 603-668-7096 Fax: 603-669-6944 | |
David T Wang, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 703 Riverway Pl, Bedford, NH 03110 Phone: 603-627-1661 Fax: 603-669-6944 | |
Dr. Robert Remington Sprague, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 703 Riverway Pl, Bedford, NH 03110 Phone: 603-627-1661 Fax: 603-669-6944 | |
Dr. Daniel Joseph Sheibley, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 703 Riverway Pl, Bedford, NH 03110 Phone: 603-627-1661 Fax: 603-669-6944 |